OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study
Mattia Bellan, Lorenza Scotti, Daniela Ferrante, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 2955-2955
Open Access | Times Cited: 6
Mattia Bellan, Lorenza Scotti, Daniela Ferrante, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 2955-2955
Open Access | Times Cited: 6
Showing 6 citing articles:
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis
Rouhin Sen, Maria Riofrio, Jasvinder A. Singh
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 6, pp. 687-714
Closed Access | Times Cited: 3
Rouhin Sen, Maria Riofrio, Jasvinder A. Singh
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 6, pp. 687-714
Closed Access | Times Cited: 3
Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age Groups
Victor Pera, Jan A. Kors, Erik M. van Mulligen, et al.
Drug Safety (2024)
Open Access | Times Cited: 2
Victor Pera, Jan A. Kors, Erik M. van Mulligen, et al.
Drug Safety (2024)
Open Access | Times Cited: 2
Reestablish immune tolerance in rheumatoid arthritis
Ziqiang Shuai, Shuang Zheng, Kang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Ziqiang Shuai, Shuang Zheng, Kang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
The Incidence, Aetiology and Clinical Course of Serious Infections Complicating Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis in Tropical Australia
Cody Price, John P. M. Wood, I. Ismail, et al.
Pathogens (2024) Vol. 13, Iss. 11, pp. 943-943
Open Access | Times Cited: 1
Cody Price, John P. M. Wood, I. Ismail, et al.
Pathogens (2024) Vol. 13, Iss. 11, pp. 943-943
Open Access | Times Cited: 1
Decreased in-hospital mortality in shock patients with rheumatoid arthritis compared to those without: a retrospective analysis of a critical care database
Jin Wan, Xiaoyu Cao, Yaran Yang
Clinical Rheumatology (2024)
Closed Access
Jin Wan, Xiaoyu Cao, Yaran Yang
Clinical Rheumatology (2024)
Closed Access
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
Michaela Koehm, Ann Christina Foldenauer, Tanja Roßmanith, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7316-7316
Open Access | Times Cited: 1
Michaela Koehm, Ann Christina Foldenauer, Tanja Roßmanith, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7316-7316
Open Access | Times Cited: 1
